Medical technology firm Stryker has expanded its spine product portfolio with the introduction of a new LITe BIO delivery system.

The new hand-held device has been developed to facilitate delivery of bone graft material to spinal surgery sites, helping surgeons to accommodate preferred graft materials.

LITe BIO system enables surgeons to use single-handed method to deliver any type of autograft, allograft or synthetic bone graft material without obstructing visibility.

The delivery tool, which offers tactile, visual and audible confirmation of bone graft delivery, eliminates the impaction of bone graft.

According to the company, the patented system can be used for any type of spine fusion surgery, including minimally invasive procedures. Its low-profile design enables visibility through a decompression tube without obstructing view.

Stryker’s spine division president Bradley Paddock said: “Our new LITe BIO Delivery System is innovative in the marketplace, simplifying graft delivery for spine surgeons.

“Its sleek, versatile design can accommodate any bone graft material and provides surgeons with direct visualization to aid in the precise placement of the graft, which is important for optimal fusion.

“No other system combines all of these key features—the LITe BIO Delivery System truly is advanced delivery, simplified.”

The company’s spine portfolio includes products and instruments, which will be used for access, interbody, fixation, and fusion.

With operations in around 100 countries, Stryker provides products and services in orthopaedics, medical and surgical, and neurotechnology and spine.